
Upadacitinib is an oral JAK inhibitor that reduces excessive immune activity and inflammation. It is prescribed for selected inflammatory conditions affecting the joints, skin or bowel when other treatments are unsuitable or have not provided adequate control.
| Generic Name | Upadacitinib |
| Strength | 30 mg |
| Manufacturer | MSN Laboratories Private Limited |
| Packing | 30 Tablets |
| Prescribed For | Suppresses an overactive immune system to treat chronic inflammatory and autoimmune conditions |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Upadacitinib blocks enzymes called Janus kinases, or JAKs, which transmit inflammatory signals within the immune system. By interrupting these signals, it reduces excessive immune activity, inflammation and tissue damage. This can help relieve joint, skin and bowel symptoms.